Atul Ltd 2020-21

102 Atul Ltd | Annual Report 2020-21 ( ` cr ) Particulars 2020-21 2019-20 Dividend received from joint venture company 1.46 2.19 Dividend received from others 56.57 17.99 Net cash used in investing activities B (602.98) (708.64) C CASH FLOW FROM FINANCING ACTIVITIES Interest paid (1.97) (2.35) Dividend on equity shares (including dividend distribution tax) - (151.34) Buy-back of equity shares (including transaction cost ) (61.74) - Net cash used in financing activities C (63.71) (153.69) Net increase | (decrease) in cash and cash equivalents A+B+C 9.82 (9.96) Cash and cash equivalents at the beginning of the year 5.43 15.39 Cash and cash equivalents at the end of the year 15.25 5.43 i) T he above Statement of Cash Flows has been prepared under the ‘Indirect Method’ as set out in the Ind AS 7 on the Statement of Cash Flows as notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended. ii) C ash flows from operating activities include ` 12.41 cr (March 31, 2020: ` 9.60 cr) being expenses towards Corporate Social Responsibility initiatives. iii) O ptionally convertible cumulative redeemable preference shares of ` 20 cr were converted to equity shares of Atul Bioscience Ltd as per the conversion option in such shares during the previous year. The accompanying Notes 1-28 form an integral part of the Standalone Financial Statements Standalone Statement of Cash Flows for the year ended March 31, 2020 In terms of our report attached For Deloitte Haskins & Sells LLP For and on behalf of the Board of Directors Chartered Accountants Samir R. Shah T R Gopi Kannan R A Shah S S Lalbhai Partner Whole-time Director and CFO B S Mehta Chairman and Managing Director L P Patni V S Rangan Company Secretary Directors S A Lalbhai Managing Director B N Mohanan Mumbai Whole-time Director Atul April 30, 2021 and President - U&S April 30, 2021